Affordable Access

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

Authors
  • Del Poeta, Giovanni
  • Del Principe, Maria Ilaria
  • Buccisano, Francesco
  • Maurillo, Luca
  • Capelli, Giovanni
  • Luciano, Fabrizio
  • Perrotti, Alessio Pio
  • Degan, Massimo
  • Venditti, Adriano
  • de Fabritiis, Paolo
  • Gattei, Valter
  • Amadori, Sergio
Type
Published Article
Journal
Cancer
Publication Date
Jan 01, 2008
Volume
112
Issue
1
Pages
119–128
Identifiers
PMID: 17999417
Source
Medline
License
Unknown

Abstract

The addition of a consolidation and maintenance therapy with rituximab prolonged response duration significantly in patients with MRD-positive B-CLL.

Report this publication

Statistics

Seen <100 times